December 2016
-
The FDA has issued a warning to parents and health care professionals after receiving reports of accidental ingestion of nasal sprays and eye drops by children. According to the agency, the decongestant nasal sprays reported… Read more . . .
-
Two companies that provide services to OINDP developers and manufacturers have been awarded major prizes recently. The 2012 British Engineering Excellence Awards recognized device design experts Team Consulting as “Consultancy of the Year.” Criteria for… Read more . . .
-
Pharmaxis’s Bronchitol mannitol dry powder for inhalation has become the first treatment for cystic fibrosis to receive a positive recommendation from he UK National Institute for Health and Clinical Excellence (NICE), according to the company.… Read more . . .
-
Northern California. The Senior Process Engineer is a lead member of the Process Development and Manufacturing team developing spray drying and micronization processes at pilot and commercial scales. Supervise the manufacturing team during manufacturing campaigns.… Read more . . .
-
Novartis has filed a marketing application with the EMA for its QVA149 indacaterol maleate/glycopyrronium bromide DPI for the treatment of COPD. The filing triggered milestone payments of $5 million each to the drug’s developers, Vectura… Read more . . .
-
According to the Associated Press, GlaxoSmithKline is extending its “Complete the Cycle” inhaler recycling program to 31 US cities, which were chosen because they account for about a third of all inhaler sales in the… Read more . . .
-
According to Pearl Therapeutics, a randomized, double-blind, dose-ranging Phase 2b study of its PT003 formoterol fumarate (FF)/glycopyrrolate (GP) MDI for the treatment of moderate-to-severe COPD in more than a thousand patients showed that several doses… Read more . . .
-
Raleigh, NC, inhalation company. This position involves managing the R&D MDI processing laboratory at our client’s Raleigh, NC site. The primary functions will be to lead the development and scale-up of the MDI filling process,… Read more . . .
-
Raleigh, NC, inhalation company. The Analytical Director will have responsibility for the strategic oversight of analytical operations including method development, validation and implementation, as well as analytical method transfers, and the support of regulatory submissions… Read more . . .
-
A number of companies that provide products and services for inhaled and nasal drugs had booths at the 2012 AAPS annual meeting. Click on thumbnails for larger versions. Read more . . .
Featured event:
5th Annual Inhaled & Nasal Biologics | DNA Forum
5th Annual Inhaled & Nasal Biologics | DNA Forum
24th-25th September 2026, Cambridge, UK
Join us for a ground-breaking and insightful forum: Two days of cutting-edge talks and networking opportunities in this complex area of drug and vaccine development.
With renowned industry leaders who will share their insights and real-world case studies, our speakers will explore innovative formulation and delivery technologies and the rationale behind overcoming development challenges. Don’t miss out on this opportunity to learn more about key topics shaping the future of inhaled therapeutics.
Get online to see speakers announced so far. Registration is live – save your seat now!
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland